INFU250117C10000
- 0.34
- 0.000.00%
InfuSystems Newsroom
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
InfuSystem Appoints Ronald Hundzinski to the Board >INFU
Express News | InfuSystem Holdings Inc - Expands Board to Eight Members From Seven
Express News | InfuSystem Appoints Ronald Hundzinski to the Board of Directors
Craig-Hallum Maintains InfuSystems(INFU.US) With Buy Rating, Announces Target Price $15
InfuSystems | 10-Q: Q3 2024 Earnings Report
B.Riley Financial Maintains InfuSystems(INFU.US) With Buy Rating, Raises Target Price to $14
B. Riley Adjusts Price Target on InfuSystem to $14 From $13, Maintains Buy Rating
InfuSystems Holdings Inc (INFU) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic ...
Lake Street Maintains InfuSystems(INFU.US) With Buy Rating, Maintains Target Price $12.5
InfuSystems Sees 2024 Net Rev Growth in High-Single-Digit Range >INFU
InfuSystems Holdings Q3 2024 GAAP EPS $0.08 Beats $0.06 Estimate, Sales $35.320M Beat $34.483M Estimate
InfuSystems | 8-K: InfuSystem Reports Third Quarter 2024 Financial Results
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Posts Q3 Revenue $35.3M
Express News | InfuSystem Holdings Inc: Reaffirms Full-Year 2024 Guidance
Express News | InfuSystem Q3 Net Income USD 1.807 Million
InfuSystems 3Q EPS 8c >INFU
NYSE American Net Change Percentage Gainers & Losers
Craig-Hallum Maintains InfuSystems(INFU.US) With Buy Rating